Koers Shanghai Yizhong Pharmaceutical Co., Ltd.
Aandelen
688091
CNE1000050F4
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
38,9 CNY | +0,13% | -4,70% | -39,22% |
Omzet 2022 | 235,96 1,71K 221,68 | Omzet 2023 | 360,25 2,61K 338,46 | Marktkapitalisatie | 10,13 mld. 73,32 mld. 9,52 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 143 mln. 1,03 mld. 134 mln. | Nettowinst (verlies) 2023 | 162 mln. 1,17 mld. 152 mln. | EV/omzet 2022 | 37.785.049 x |
Nettoliquiditeiten 2022 | 1,13 mld. 8,16 mld. 1,06 mld. | Nettoliquiditeiten 2023 | 1,2 mld. 8,66 mld. 1,12 mld. | EV/omzet 2023 | 24.797.961 x |
K/w-verhouding 2022 |
70,5
x | K/w-verhouding 2023 |
62,7
x | Werknemers | 304 |
Dividendrendement 2022 |
0,43% | Dividendrendement 2023 |
0,48% | Vrij verhandelbaar | 39,29% |
1 dag | +0,13% | ||
1 week | -4,70% | ||
Lopende maand | -9,24% | ||
1 maand | -20,71% | ||
3 maanden | -34,61% | ||
6 maanden | -26,13% | ||
Lopend jaar | -39,22% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Duan Li
FOU | Founder | 84 | 10-09-09 |
Jin Song Zhou
CEO | Chief Executive Officer | 56 | 10-09-09 |
Ruo Yun Pan
CHM | Chairman | 43 | 01-08-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jin Song Zhou
CEO | Chief Executive Officer | 56 | 10-09-09 |
Duan Li
FOU | Founder | 84 | 10-09-09 |
Jing Sun
BRD | Director/Board Member | 47 | 01-10-09 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 34 M€ | +1,04% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
18-04-24 | 38,9 | +0,13% | 1 129 098 |
17-04-24 | 38,85 | +1,15% | 1 302 392 |
16-04-24 | 38,41 | -2,81% | 1 222 734 |
15-04-24 | 39,52 | -1,57% | 1 144 049 |
12-04-24 | 40,15 | -1,64% | 1 289 613 |
slotkoers Shanghai S.E., 18 april 2024
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-39,22% | 849 mln. | |
+11,18% | 9,08 mld. | |
-15,94% | 4,57 mld. | |
+18,47% | 3,9 mld. | |
+1,89% | 3,69 mld. | |
+28,61% | 2,62 mld. | |
-24,63% | 2,34 mld. | |
-29,37% | 2,14 mld. | |
+2,55% | 1,84 mld. | |
-0,50% | 1,64 mld. |